Mining the Human Tissue Proteome for Protein Citrullination *

Citrullination is a posttranslational modification of arginine catalyzed by five peptidylarginine deiminases (PADs) in humans. The loss of a positive charge may cause structural or functional alterations, and while the modification has been linked to several diseases, including rheumatoid arthritis (RA) and cancer, its physiological or pathophysiological roles remain largely unclear. In part, this is owing to limitations in available methodology to robustly enrich, detect, and localize the modification. As a result, only a few citrullination sites have been identified on human proteins with high confidence. In this study, we mined data from mass-spectrometry-based deep proteomic profiling of 30 human tissues to identify citrullination sites on endogenous proteins. Database searching of ∼70 million tandem mass spectra yielded ∼13,000 candidate spectra, which were further triaged by spectrum quality metrics and the detection of the specific neutral loss of isocyanic acid from citrullinated peptides to reduce false positives. Because citrullination is easily confused with deamidation, we synthetized ∼2,200 citrullinated and 1,300 deamidated peptides to build a library of reference spectra. This led to the validation of 375 citrullination sites on 209 human proteins. Further analysis showed that >80% of the identified modifications sites were new, and for 56% of the proteins, citrullination was detected for the first time. Sequence motif analysis revealed a strong preference for Asp and Gly, residues around the citrullination site. Interestingly, while the modification was detected in 26 human tissues with the highest levels found in the brain and lung, citrullination levels did not correlate well with protein expression of the PAD enzymes. Even though the current work represents the largest survey of protein citrullination to date, the modification was mostly detected on high abundant proteins, arguing that the development of specific enrichment methods would be required in order to study the full extent of cellular protein citrullination.

[1]  Jennifer E. Grant,et al.  An in silico analysis of primary and secondary structure specificity determinants for human peptidylarginine deiminase types 2 and 4 , 2017, Comput. Biol. Chem..

[2]  Guang-Yaw Liu,et al.  Probing the Roles of Calcium-Binding Sites during the Folding of Human Peptidylarginine Deiminase 4 , 2017, Scientific Reports.

[3]  Mathias Wilhelm,et al.  Building ProteomeTools based on a complete synthetic human proteome , 2017, Nature Methods.

[4]  Jüergen Cox,et al.  The MaxQuant computational platform for mass spectrometry-based shotgun proteomics , 2016, Nature Protocols.

[5]  T. Warner,et al.  Tumor necrosis factor alpha, citrullination, and peptidylarginine deiminase 4 in lung and joint inflammation , 2016, Arthritis Research & Therapy.

[6]  P. Thompson,et al.  Protein Arginine Methylation and Citrullination in Epigenetic Regulation , 2015, ACS chemical biology.

[7]  José A. Dianes,et al.  2016 update of the PRIDE database and its related tools , 2015, Nucleic Acids Res..

[8]  P. Thompson,et al.  Chemical Proteomic Platform To Identify Citrullinated Proteins , 2015, ACS chemical biology.

[9]  Paul R Thompson,et al.  Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation. , 2015, Current drug targets.

[10]  Stuart A. Wilson,et al.  Arginine methylation and citrullination of splicing factor proline- and glutamine-rich (SFPQ/PSF) regulates its association with mRNA , 2015, RNA.

[11]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[12]  G. D. de Souza,et al.  Assessing the citrullinome in rheumatoid arthritis synovial fluid with and without enrichment of citrullinated peptides. , 2014, Journal of proteome research.

[13]  J. Drijfhout,et al.  The human peptidylarginine deiminases type 2 and type 4 have distinct substrate specificities. , 2014, Biochimica et biophysica acta.

[14]  A. Stensballe,et al.  Optimizing the Identification of Citrullinated Peptides by Mass Spectrometry: Utilizing the Inability of Trypsin to Cleave after Citrullinated Amino Acids , 2013 .

[15]  G. Pruijn,et al.  Methods for the Detection of Peptidylarginine Deiminase (PAD) Activity and Protein Citrullination* , 2013, Molecular & Cellular Proteomics.

[16]  B. Fleckenstein,et al.  Specific biotinylation and sensitive enrichment of citrullinated peptides , 2013, Analytical and Bioanalytical Chemistry.

[17]  Jennifer E Van Eyk,et al.  Identification and characterization of citrulline‐modified brain proteins by combining HCD and CID fragmentation , 2013, Proteomics.

[18]  A. Dannenberg,et al.  Identification of Macrophage Extracellular Trap-Like Structures in Mammary Gland Adipose Tissue: A Preliminary Study , 2013, Front. Immunol..

[19]  G. Pruijn,et al.  Peptidylarginine deiminase expression and activity in PAD2 knock-out and PAD4-low mice. , 2013, Biochimie.

[20]  R. Nagele,et al.  Neuronal PAD4 expression and protein citrullination: possible role in production of autoantibodies associated with neurodegenerative disease. , 2012, Journal of autoimmunity.

[21]  M. Dhaenens,et al.  In vivo relevance of citrullinated proteins and the challenges in their detection , 2012, Proteomics.

[22]  P. Thompson,et al.  Purification of enzymatically inactive peptidylarginine deiminase type 6 from mouse ovary that reveals hexameric structure different from other dimeric isoforms , 2011 .

[23]  M. Selbach,et al.  Global quantification of mammalian gene expression control , 2011, Nature.

[24]  M. Puszczewicz,et al.  Role of anti-citrullinated protein antibodies in diagnosis and prognosis of rheumatoid arthritis , 2011, Archives of medical science : AMS.

[25]  M. Mann,et al.  Andromeda: a peptide search engine integrated into the MaxQuant environment. , 2011, Journal of proteome research.

[26]  Patricia Stadtmüller,et al.  A technique for the specific enrichment of citrulline-containing peptides. , 2010, Analytical biochemistry.

[27]  P. Thompson,et al.  Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3. , 2010, Biochemistry.

[28]  G. Pruijn,et al.  The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis , 2010, Arthritis research & therapy.

[29]  M. Penrad-Mobayed,et al.  Novel domains in the hnRNP G/RBMX protein with distinct roles in RNA binding and targeting nascent transcripts , 2010, Nucleus.

[30]  M. Feldmann,et al.  Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis , 2010, Immunological reviews.

[31]  A. Hartmann,et al.  Heterogeneous Nuclear Ribonucleoprotein G Regulates Splice Site Selection by Binding to CC(A/C)-rich Regions in Pre-mRNA* , 2009, Journal of Biological Chemistry.

[32]  L. Tora,et al.  PRMT1 mediated methylation of TAF15 is required for its positive gene regulatory function. , 2009, Experimental cell research.

[33]  Israel Steinfeld,et al.  BMC Bioinformatics BioMed Central , 2008 .

[34]  P. Jani,et al.  Inflammatory mechanisms in the lung , 2008, Journal of inflammation research.

[35]  F. Mastronardi,et al.  The Role of Citrullinated Proteins Suggests a Novel Mechanism in the Pathogenesis of Multiple Sclerosis , 2006, Neurochemical Research.

[36]  L. Klareskog,et al.  Citrullination is an inflammation-dependent process , 2006, Annals of the rheumatic diseases.

[37]  M. Stallcup,et al.  Regulation of coactivator complex assembly and function by protein arginine methylation and demethylimination. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Simon,et al.  Peptidylarginine deiminase isoforms 1-3 are expressed in the epidermis and involved in the deimination of K1 and filaggrin. , 2005, The Journal of investigative dermatology.

[39]  I. Sargent,et al.  Preeclampsia and the systemic inflammatory response. , 2004, Seminars in nephrology.

[40]  R. Aebersold,et al.  A statistical model for identifying proteins by tandem mass spectrometry. , 2003, Analytical chemistry.

[41]  A. Nicholas,et al.  Immunohistochemical localization of citrullinated proteins in adult rat brain , 2003, The Journal of comparative neurology.

[42]  A. Ishigami,et al.  cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type I. , 2003, The Biochemical journal.

[43]  A. Ishigami,et al.  Human peptidylarginine deiminase type II: molecular cloning, gene organization, and expression in human skin. , 2002, Archives of biochemistry and biophysics.

[44]  A. Ishigami,et al.  Immunocytochemical localization of peptidylarginine deiminase in human eosinophils and neutrophils , 2001, Journal of leukocyte biology.

[45]  A. Yoshiki,et al.  Human peptidylarginine deiminase type III: molecular cloning and nucleotide sequence of the cDNA, properties of the recombinant enzyme, and immunohistochemical localization in human skin. , 2000, The Journal of investigative dermatology.

[46]  A. Ishigami,et al.  Molecular Characterization of Peptidylarginine Deiminase in HL-60 Cells Induced by Retinoic Acid and 1α,25-Dihydroxyvitamin D3 * , 1999, The Journal of Biological Chemistry.

[47]  M. Moscarello,et al.  The developmental expression and activity of peptidylarginine deiminase in the mouse , 1999, Neuroscience Letters.

[48]  B W Gibson,et al.  Low-mass ions produced from peptides by high-energy collision-induced dissociation in tandem mass spectrometry , 1993, Journal of the American Society for Mass Spectrometry.

[49]  G. Hein,et al.  The interaction of trypsin with neutral substrates and modifiers. , 1968, Biochemistry.

[50]  B. Kuster,et al.  Hydrophilic Strong Anion Exchange (hSAX) Chromatography Enables Deep Fractionation of Tissue Proteomes. , 2017, Methods in molecular biology.

[51]  John I. Clark,et al.  Assigning in vivo carbamylation and acetylation in human lens proteins using tandem mass spectrometry and database searching , 2007 .

[52]  András Falus,et al.  Citrullination: a posttranslational modification in health and disease. , 2006, The international journal of biochemistry & cell biology.

[53]  K. Ying,et al.  cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type VI. , 2004, Acta biochimica Polonica.

[54]  I. Vidavsky,et al.  Comparing similar spectra: From similarity index to spectral contrast angle , 2002, Journal of the American Society for Mass Spectrometry.

[55]  F. V. D. van den Hoogen,et al.  Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. , 1998, The Journal of clinical investigation.